Nathalie Levasseur on Fatigue and Exercise in Patients with Breast Cancer

Video

Nathalie Levasseur, MD, from University of Ottawa, discusses encouraging patients with breast cancer to exercise.

Fatigue during treatment is a reality and that can affect a person’s motivation for exercise. For postmenopausal women, there are additional physiological changes. Levasseur suggests patients start small with exercise, and then increase activity gradually. This is a difficult area for oncology practitioners as well, because of a lack of evidence to guide them.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, in an interview with Oncology Nursing News
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
TIL Presence in TNBC May Indicate Improved Survival

TIL Presence in TNBC May Indicate Improved Survival

May 13th 2024
Article

Patients with triple-negative breast cancer with an increased TIL count in breast tissue were more likely to have an improved distant recurrence-free survival.

The Vitals

Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

November 15th 2023
Podcast

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

Trastuzumab Deruxtecan Enhances PFS in Metastatic HR+/HER2-Low Breast Cancer

Trastuzumab Deruxtecan Enhances PFS in Metastatic HR+/HER2-Low Breast Cancer

April 30th 2024
Article

Trastuzumab deruxtecan enhanced survival without disease progression compared with chemotherapy in HR-positive, HER2-low metastatic breast cancer after 1 or more lines of endocrine therapy.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Trastuzumab Biosimilar Receives FDA Approval for HER2-Overexpressing Breast and Gastric/GEJ Cancers

Trastuzumab Biosimilar Receives FDA Approval for HER2-Overexpressing Breast and Gastric/GEJ Cancers

April 29th 2024
Article

Trastuzumab-strf was approved for HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or GEJ adenocarcinoma.

Nurse Intervention Approach Feasible in Addressing Cancer Symptom Clusters

Nurse Intervention Approach Feasible in Addressing Cancer Symptom Clusters

April 28th 2024
Article

A pilot study proved that a nurse-coordinated approach shows promise in treating more than just 1 symptom among patients with cancer.

© 2024 MJH Life Sciences

All rights reserved.